$FRX Recent News Earnings boost Micron, drag on Container

New Post Public Reply Private Reply Replies (0) Message Board

Jan 11, 2014 at 9:19 PM

$FRX Recent News

Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
U.S. stocks end lower after Fed minutes 4:24 p.m. Jan. 8, 2014 - Anora Mahmudova
Stock market live blog (recap): Dow, S&P 500 end lower after Fed minutes 4:04 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Forest shares see double-digit gains following Aptalis purchase 11:03 a.m. Jan. 8, 2014 - Russ Britt
Forest Laboratories acquires Aptalis for $2.9 bln 7:50 a.m. Jan. 8, 2014 - Saumya Vaishampayan
Forest Laboratories acquires Aptalis for $2.9 bln 7:45 a.m. Jan. 8, 2014 - Saumya Vaishampayan
Facebook, Twitter, Yahoo are stocks to watch 1:57 p.m. Dec. 24, 2013 - Wallace Witkowski
Stocking stuffer stocks for 2014 10:52 a.m. Dec. 23, 2013 - The Trading Deck
S&P shifts to ‘good news is good news’ backdrop 12:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Dow set to open below 16,000; Apple rises 8:53 a.m. Dec. 3, 2013 - William L. Watts
Forest Laboratories to cut 9% of workforce 11:39 p.m. Dec. 2, 2013 - MarketWatch.com
EBay outperforms Amazon on Cyber Monday 4:16 p.m. Dec. 2, 2013 - Sue Chang
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - Russ Britt
Forest Labs to cut $500 mln in costs, R&D 9:55 a.m. Dec. 2, 2013 - MarketWatch.com
Apple snaps winning streak; Netflix rewinds 3:59 p.m. Oct. 22, 2013 - Sue Chang
Changing of the guard at Forest Labs placates Icahn — for now 3:50 p.m. Sept. 10, 2013 - Russ Britt
Forest Labs Fetzima Gets FDA OK on depression drug 8:06 a.m. July 26, 2013 - MarketWatch.com
Forest Labs investors see the light; swing shares to a gain near close 2:38 p.m. July 23, 2013 - Russ Britt
Centene, Forest each beat earnings views, but diverge in market woods 10:16 a.m. July 23, 2013 - Russ Britt
Forest Labs net falls 58% on lower Lexapro sales 7:06 a.m. July 23, 2013 - MarketWatch.com

Ironwood Up on Job Cut Plans - Analyst Blog 6:30 p.m. Jan. 10, 2014 - Zacks.com
Aegerion Gives Preliminary 2013 Update - Analyst Blog 5:10 p.m. Jan. 10, 2014 - Zacks.com
ENDP Agrees to Sell HealthTronics Unit - Analyst Blog 11:40 a.m. Jan. 10, 2014 - Zacks.com
SA PRO: Top Long And Short Ideas, Thursday January 9 7:30 a.m. Jan. 10, 2014 - Seeking Alpha
NuPathe Soars on Teva Offer - Analyst Blog 3:05 p.m. Jan. 9, 2014 - Zacks.com
Forest Labs Soars on Aptalis Deal - Analyst Blog 1:10 p.m. Jan. 9, 2014 - Zacks.com
Update on AMAG's Feraheme - Analyst Blog 1:00 p.m. Jan. 9, 2014 - Zacks.com
Positive Data on BioSpecifics/ Auxilium's Xiaflex - Analyst Blog 12:10 p.m. Jan. 9, 2014 - Zacks.com
NPSP Provides Rosy Gattex Outlook, Shares up - Analyst Blog 11:40 a.m. Jan. 9, 2014 - Zacks.com
Forest Branches Out With $2.9B Purchase of Rival 9:48 a.m. Jan. 9, 2014 - Barrons.com
Wall Street Breakfast: Must-Know News 6:33 a.m. Jan. 9, 2014 - Seeking Alpha
New Data on Pacira's Exparel - Analyst Blog 6:11 p.m. Jan. 8, 2014 - Zacks.com
Oculus Introduces Two Products - Analyst Blog 5:10 p.m. Jan. 8, 2014 - Zacks.com
AZN and Horizon Discovery Ink Deal - Analyst Blog 5:02 p.m. Jan. 8, 2014 - Zacks.com
Affymetrix Up on Upbeat Rev Guidance - Analyst Blog 4:45 p.m. Jan. 8, 2014 - Zacks.com
FDA lists four new drugs mentioned in Paragraph IV ANDAs 3:59 p.m. Jan. 8, 2014 - Seeking Alpha
Valeant Provides Strong Guidance, Shares Up - Analyst Blog 2:20 p.m. Jan. 8, 2014 - Zacks.com
The Deal: Forest Widens Business, Pays $2.9 Billion for Aptalis 2:06 p.m. Jan. 8, 2014 - TheStreet.com
Abraxane Label Expansion Lifts Celgene - Analyst Blog 11:30 a.m. Jan. 8, 2014 - Zacks.com
Forest Buying Aptalis; Teva Bids For NuPathe Vs. Endo 10:24 a.m. Jan. 8, 2014 - Investors Business Daily

Adamas Pharmaceuticals Earns $40 Million in Milestone Payments from Forest Laboratories for MDX-8704 9:00 a.m. Jan. 9, 2014 - PR Newswire
Trevena Announces Dosing of First Patient in Phase 2b BLAST-AHF Trial of TRV027 for Acute Heart Failure 6:59 a.m. Jan. 9, 2014 - BusinessWire
Aptalis to be Acquired by Forest Laboratories for $2.9 Billion 7:36 a.m. Jan. 8, 2014 - BusinessWire
Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash 7:29 a.m. Jan. 8, 2014 - BusinessWire
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
moksha8 files for regulatory approval of Viibryd® and Colobreathe in Brazil and amends alliance with Forest Laboratories 8:00 a.m. Jan. 6, 2014 - PR Newswire
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 Third Quarter Earnings 3:59 p.m. Jan. 2, 2014 - BusinessWire
Drug Availability, Clinical Trial Partnerships, Labeling Discussions, Stock Updates, and Credit Facilities - Research Report on Forest Laboratories, Oxygen Biotherapeutics, Alimera, pSivida and AcelRx 8:00 a.m. Dec. 24, 2013 - PR Newswire
Forest Announces New FETZIMA(TM) (levomilnacipran ER capsules) Now Available in Pharmacies Throughout U.S. 8:00 a.m. Dec. 19, 2013 - BusinessWire
Stock Price Updates, Dividends Declaration, and Appointments in Executive Leadership Team - Research Report on Humana, Illumina, Forest Laboratories, Stryker, and Unilife 8:00 a.m. Dec. 16, 2013 - PR Newswire
Forest Laboratories Announces Appointments to its Executive Team 9:00 a.m. Dec. 9, 2013 - BusinessWire
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin 8:00 a.m. Dec. 6, 2013 - PR Newswire
Forest Laboratories, Inc. Upsizes and Prices Offering of $1.2 Billion of Senior Notes Due 2021 4:36 p.m. Dec. 5, 2013 - BusinessWire
Marketing Rights Acquisitions, PDUFA Date Extensions, Accountable Care Relationship and Stock Price Updates - Research Report on Forest Laboratories, Biogen, Bristol-Myers, Express Scripts, and Aetna 8:00 a.m. Dec. 5, 2013 - PR Newswire
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck 9:00 a.m. Dec. 2, 2013 - BusinessWire
Forest Laboratories, Inc. Announces Private Placement of Senior Notes and Amendment to Existing $750 Million Revolver 8:30 a.m. Dec. 2, 2013 - BusinessWire
Forest Announces Major New Plans to Streamline Operations, Leverage Balance Sheet and Repurchase Common Stock 8:30 a.m. Dec. 2, 2013 - BusinessWire
Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare 8:00 a.m. Nov. 27, 2013 - PR Newswire
Today's Research: Celgene Corp., Forest Laboratories Inc., Edwards Lifesciences Corp., and Peregrine Pharma Inc. 1:30 p.m. Nov. 22, 2013 - PR Newswire
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine 2:00 a.m. Nov. 21, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Air Sealing First: Boosting Home Comfort & Efficiency

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...